Test–retest reliability of ski‐specific aerobic, sprint, and neuromuscular performance tests in highly trained cross‐country skiers
Scandinavian Journal of Medicine & Science in Sports · 2023
DOI: 10.1111/sms.14473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Medicine & Science in Sports, 2023. Verfasst von Elias Bucher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section for Elite Sport, Swiss Federal Institute of Sport Magglingen, Magglingen, Switzerland. Hauptthemen laut MEDLINE: Skiing, Athletic Performance. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Swiss Federal Institute of Sport, Magglingen.
Abstract (Originalsprache)
Purpose
Laboratory tests are commonly performed by cross‐country (XC) skiers due to the challenges of obtaining reliable performance indicators on snow. However, only a few studies have reported reliability data for ski‐specific test protocols. Therefore, this study examined the test–retest reliability of ski‐specific aerobic, sprint, and neuromuscular performance tests.
Methods
Thirty‐nine highly trained XC skiers (26 men and 13 women, age: 22 ± 4 years, V̇O 2max : 70.1 ± 4.5 and 58.8 ± 4.4 mL·kg −1 ·min −1 , respectively) performed two test trials within 6 days of a diagonal V̇O 2max test, n = 27; skating graded exercise test to assess the second lactate threshold (LT 2 ), n = 27; 24‐min double poling time trial (24‐min DP, n = 25), double poling sprint test (Sprint DP1 , n = 27), and 1‐min self‐paced skating sprint test (Sprint 1‐min , n = 26) using roller skis on a treadmill, and an upper‐body strength test (UB‐ST, n = 27) to assess peak power ( P peak ) with light, medium, and heavy loads. For each test, the coefficient of variation (CV), intraclass correlation coefficient (ICC), and minimal detectable change (MDC) were calculated.
Results
V̇O 2max demonstrated good‐to‐excellent reliability (CV = 1.4%; ICC = 0.99; MDC = 112 mL·min −1 ), whereas moderate‐to‐excellent reliability was found for LT 2 (CV = 3.1%; ICC = 0.95). Performance during 24‐min DP, Sprint DP1 , and Sprint 1‐min showed good‐to‐excellent reliability (CV = 1.0%–2.3%; ICC = 0.96–0.99). Absolute reliability for UB‐ST P peak was poor (CV = 4.9%–7.8%), while relative reliability was excellent (ICC = 0.93–0.97) across the loads.
Conclusion
In highly trained XC skiers, sport‐specific aerobic and sprint performance tests demonstrated high test–retest reliability, while neuromuscular performance for the upper body was less reliable. Using the presented protocols, practitioners can assess within‐ and between‐season changes in relevant performance indicators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section for Elite Sport, Swiss Federal Institute of Sport Magglingen, Magglingen, Switzerland.
- Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland.
ORCID-Profile: Elias Bucher, Grégoire P Millet, Jon P Wehrlin, Thomas Steiner
Förderung
- The Swiss Federal Institute of Sport, Magglingen
Zitieren
APA
Bucher, E., Millet, G. P., Wehrlin, J. P., & Steiner, T. (2023). Test–retest reliability of ski‐specific aerobic, sprint, and neuromuscular performance tests in highly trained cross‐country skiers. Scandinavian Journal of Medicine & Science in Sports. https://doi.org/10.1111/sms.14473
Vancouver
Bucher E, Millet GP, Wehrlin JP, Steiner T. Test–retest reliability of ski‐specific aerobic, sprint, and neuromuscular performance tests in highly trained cross‐country skiers. Scandinavian Journal of Medicine & Science in Sports. 2023. doi:10.1111/sms.14473
BibTeX
@article{Bucher2023,
author = {Bucher, Elias and Millet, Grégoire P and Wehrlin, Jon P and Steiner, Thomas},
title = {Test–retest reliability of ski‐specific aerobic, sprint, and neuromuscular performance tests in highly trained cross‐country skiers},
journal = {Scandinavian Journal of Medicine & Science in Sports},
year = {2023},
doi = {10.1111/sms.14473}
}
EUVIMED